Find topics, guides & solutions
In-depth articles, guides, and insights to help you understand Demodex, improve your skin, and take control of your health.
Leaky gut and rosacea: two small zonulin studies, a common test that may not measure zonulin at all, and the named gut diseases the stronger...
Read More →
Ivermectin vs metronidazole is not a simple win. The head-to-head trial, the 2026 network meta-analysis, a low-mite split-face study and one dermoscopy sign, in order.
Read More →
Roflumilast for seborrheic dermatitis clears the rash without touching the yeast. What the phase 3 numbers say, what the 58 percent vehicle arm tells you...
Read More →
Ketoconazole shampoo cleared 88 percent of patients in trial conditions. Most people never reproduce those conditions. The three dosing errors, and the maintenance data that...
Read More →
Sunscreen for rosacea is the one measure patients report most and follow least. What UV does to the cascade, what phototherapy studies show about Demodex...
Read More →
IPL for rosacea targets the endpoint almost every drug leaves behind: the redness and the vessels. What the evidence supports, and the 20 percent figure...
Read More →
Every other rosacea drug attacks the organism or the inflammation. Isotretinoin for rosacea changes the food supply itself. What the trials show, and the three...
Read More →
Benzoyl peroxide for rosacea was off limits for thirty years, then two phase 3 trials changed the advice. What the microcapsule actually changed, and why...
Read More →
PCOS and Demodex research shows mite positivity tracks oily skin and acne inside the PCOS group rather than the diagnosis itself. What that means for...
Read More →
Rosacea types 1 to 4 were formally replaced by a phenotype approach in 2017 because features span more than one subtype. What the current criteria...
Read More →